fashion -WSS

fashion

author：comprehensive 2025-10-01 17:57:04 - browse：48686

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Shingles, which affected Dianne Feinstein, is on the rise

focus

WSS

Just how do doctors, lawmakers, and the public define abortion?

Address the ethical violations that led to 'Three Identical Strangers'

Researchers use wearables data and AI to predict preterm birth risk

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Kaiser Permanente unions announce official strike date

In his State of the Union, Biden takes clear aim at 'Big Pharma'

focus

fashion

knowledge

Malaria cases in Florida and Texas: Here’s what you need to know

Cigna to pay $172 million to settle Medicare Advantage fraud probe

DIEP, the 'gold standard' of breast reconstruction, is under threat

Sudafed saga points to U.S. issues with evaluating older drugs

Anesthesiologist group: stop taking Ozempic before surgery

How to bring more disabled researchers into academia

Apple is now the first public company to be valued at $3 trillion

Kaiser Permanente unions announce official strike date

Walensky prepares to leave CDC — and Congress — behind

CDC marks new Covid

hotspot

Address the ethical violations that led to 'Three Identical Strangers'

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Amylyx ALS drug failure raises questions and concerns

Senator probes 340B programs at Cleveland Clinic, Bon Secours

focus

hotspot

focus

hotspot